Your account is not claimed yet. You can sign up with ORCID to claim your account.

Weiqi Hong (Hong Weiqi)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 32

Top Venues

Signal transduction and targeted therapy

MedComm

Nature communications

Cellular & molecular immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Cai He, Aqu Alu, Hong Lei, Jingyun Yang, Weiqi Hong, Xiangrong Song, Jiong Li, Li Yang, Wei Wang, Guobo Shen, Guangwen Lu, Yanping Qian
A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2. MedComm 4 (3) (2023)
Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Yanping Qian, Zhenhua Shao
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature communications 14 (1) (2023)
Dandan Peng, Tingmei Zhao, Weiqi Hong, Minyang Fu, Cai He, Li Chen, Wenyan Ren, Hong Lei, Jingyun Yang, Aqu Alu, Yanghong Ni, Jian Liu, Jiong Li, Wei Wang, Guobo Shen, Zhiwei Zhao, Li Yang, Jinliang Yang, Zhenling Wang, Yoshimasa Tanaka, Guangwen Lu, Xiangrong Song, Yanping Qian
Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5-included SARS-CoV-2 variants than homologous vaccination of mRNA vaccine. MedComm 4 (2) (2023)
Hong Lei, Aqu Alu, Jingyun Yang, Xi He, Cai He, Wenyan Ren, Zimin Chen, Weiqi Hong, Li Chen, Xuemei He, Li Yang, Jiong Li, Zhenling Wang, Wei Wang, Yuquan Wei, Shuai-Yao Lu, Guang-Wen Lu, Xiangrong Song, Yanping Qian
Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants. Nature communications 14 (1) (2023)
Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Yanping Qian, Zhenhua Shao
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature communications 14 (1) (2023)
Hong Lei, Aqu Alu, Jingyun Yang, Xi He, Cai He, Wenyan Ren, Zimin Chen, Weiqi Hong, Li Chen, Xuemei He, Li Yang, Jiong Li, Zhenling Wang, Wei Wang, Yuquan Wei, Shuai-Yao Lu, Guang-Wen Lu, Xiangrong Song, Yanping Qian
Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants. Nature communications 14 (1) (2023)
Jingyun Yang, Weiqi Hong, Hong Lei, Cai He, Wenwen Lei, Yanan Zhou, Tingmei Zhao, Aqu Alu, Xuelei Ma, Jiong Li, Li Yang, Zhenling Wang, Wei Wang, Guang-Wen Lu, Guobo Shen, Shuai-Yao Lu, Guizhen Wu, Huashan Shi, Yanping Qian
Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection. Signal transduction and targeted therapy 8 (1) (2023)
Cai He, Aqu Alu, Hong Lei, Jingyun Yang, Weiqi Hong, Xiangrong Song, Jiong Li, Li Yang, Wei Wang, Guobo Shen, Guangwen Lu, Yanping Qian
A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2. MedComm 4 (3) (2023)
Jie Zhao, Hong Fu, Jingjing Yu, Weiqi Hong, Xiaowen Tian, Jieyu Qi, Suyue Sun, Chang Zhao, Chao Wu, Zheng Xu, Lin Cheng, Renjie Chai, Wei Yan, Yanping Qian, Zhenhua Shao
Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature communications 14 (1) (2023)
Hong Lei, Aqu Alu, Jingyun Yang, Xi He, Cai He, Wenyan Ren, Zimin Chen, Weiqi Hong, Li Chen, Xuemei He, Li Yang, Jiong Li, Zhenling Wang, Wei Wang, Yuquan Wei, Shuai-Yao Lu, Guang-Wen Lu, Xiangrong Song, Yanping Qian
Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants. Nature communications 14 (1) (2023)
Dandan Peng, Tingmei Zhao, Weiqi Hong, Minyang Fu, Cai He, Li Chen, Wenyan Ren, Hong Lei, Jingyun Yang, Aqu Alu, Yanghong Ni, Jian Liu, Jiong Li, Wei Wang, Guobo Shen, Zhiwei Zhao, Li Yang, Jinliang Yang, Zhenling Wang, Yoshimasa Tanaka, Guangwen Lu, Xiangrong Song, Yanping Qian
Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5-included SARS-CoV-2 variants than homologous vaccination of mRNA vaccine. MedComm 4 (2) (2023)
Danyi Ao, Xuemei He, Weiqi Hong, Yanping Qian
The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants. MedComm 4 (2) (2023)
Danyi Ao, Xuemei He, Weiqi Hong, Yanping Qian
The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants. MedComm 4 (2) (2023)
Weiqi Hong, Jingyun Yang, Jun Zou, Zhenfei Bi, Cai He, Hong Lei, Xuemei He, Xue Li, Aqu Alu, Wenyan Ren, Zeng Wang, Xiaohua Jiang, Kunhong Zhong, Guowen Jia, Yun Yang, Wenhai Yu, Qing Huang, Mengli Yang, Yanan Zhou, Yuan Zhao, Dexuan Kuang, Junbin Wang, Haixuan Wang, Siyuan Chen, Min Luo, Ziqi Zhang, Tianqi Lu, Li Chen, Haiying Que, Zhiyao He, Qiu Sun, Wei Wang, Guobo Shen, Guangwen Lu, Zhiwei Zhao, Li Yang, Jinliang Yang, Zhenling Wang, Jiong Li, Xiangrong Song, Lunzhi Dai, Chong Chen, Jia Geng, Maling Gou, Lu Chen, Haohao Dong, Yong Peng, Canhua Huang, Zhiyong Qian, Wei Cheng, Changfa Fan, Yuquan Wei, Zhaoming Su, Aiping Tong, Shuai-Yao Lu, Xiaozhong Peng, Yanping Qian
Histones released by NETosis enhance the infectivity of SARS-CoV-2 by bridging the spike protein subunit 2 and sialic acid on host cells. Cellular & molecular immunology 19 (5) (2022)
Cai He, Jingyun Yang, Weiqi Hong, Zimin Chen, Dandan Peng, Hong Lei, Aqu Alu, Xuemei He, Zhenfei Bi, Xiaohua Jiang, Guowen Jia, Yun Yang, Yanan Zhou, Wenhai Yu, Cong Tang, Qing Huang, Mengli Yang, Bai Li, Jingmei Li, Junbin Wang, Haiying Que, Li Chen, Wenyan Ren, Dandan Wan, Jiong Li, Wei Wang, Guobo Shen, Zhiwei Zhao, Li Yang, Jinliang Yang, Zhenling Wang, Zhaoming Su, Yuquan Wei, Xiaobo Cen, Yoshimasa Tanaka, Xiangrong Song, Shuai-Yao Lu, Xiaozhong Peng, Guang-Wen Lu, Yanping Qian
A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant. Nature communications 13 (1) (2022)
Jiayu Huang, Weiqi Hong, Meihua Wan, Limin Zheng
Molecular mechanisms and therapeutic target of NETosis in diseases. MedComm 3 (3) (2022)
Haiying Que, Weiqi Hong, Tianxia Lan, Hao Zeng, Li Chen, Dandan Wan, Zhenfei Bi, Wenyan Ren, Min Luo, Jingyun Yang, Cai He, Ailing Zhong, Yanping Qian
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal transduction and targeted therapy 7 (1) (2022)
Cai He, Xuemei He, Jingyun Yang, Hong Lei, Weiqi Hong, Xiangrong Song, Li Yang, Jiong Li, Wei Wang, Guobo Shen, Guang-Wen Lu, Yanping Qian
Spike protein of SARS-CoV-2 Omicron (B.1.1.529) variant have a reduced ability to induce the immune response. Signal transduction and targeted therapy 7 (1) (2022)
Haiying Que, Weiqi Hong, Tianxia Lan, Hao Zeng, Li Chen, Dandan Wan, Zhenfei Bi, Wenyan Ren, Min Luo, Jingyun Yang, Cai He, Ailing Zhong, Yanping Qian
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal transduction and targeted therapy 7 (1) (2022)
Xuemei He, Weiqi Hong, Jingyun Yang, Hong Lei, Tianqi Lu, Cai He, Zhenfei Bi, Xiangyu Pan, Yu Liu, Lunzhi Dai, Wei Wang, Canhua Huang, Hongxin Deng, Yanping Qian
Correction: Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine. Signal transduction and targeted therapy 7 (1) (2022)
Haiying Que, Weiqi Hong, Tianxia Lan, Hao Zeng, Li Chen, Dandan Wan, Zhenfei Bi, Wenyan Ren, Min Luo, Jingyun Yang, Cai He, Ailing Zhong, Yanping Qian
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal transduction and targeted therapy 7 (1) (2022)
Haiying Que, Weiqi Hong, Tianxia Lan, Hao Zeng, Li Chen, Dandan Wan, Zhenfei Bi, Wenyan Ren, Min Luo, Jingyun Yang, Cai He, Ailing Zhong, Yanping Qian
Tripterin liposome relieves severe acute respiratory syndrome as a potent COVID-19 treatment. Signal transduction and targeted therapy 7 (1) (2022)
Wang Manni, Xue Jianxin, Weiqi Hong, Chen Siyuan, Shi Huashan
JMJD family proteins in cancer and inflammation. Signal transduction and targeted therapy 7 (1) (2022)
Jiayuan Ai, Weiqi Hong, Min Wu, Yanping Qian
Pulmonary vascular system: A vulnerable target for COVID-19. MedComm 2 (4) (2021)
Li Chen, Weiqi Hong, Wenyan Ren, Ting Xu, Zhiyong Qian, Zhiyao He
Recent progress in targeted delivery vectors based on biomimetic nanoparticles. Signal transduction and targeted therapy 6 (1) (2021)
Zhenfei Bi, Weiqi Hong, Haiying Que, Cai He, Wenyan Ren, Jingyun Yang, Tianqi Lu, Li Chen, Shuai-Yao Lu, Xiao-Zhong Peng, Yanping Qian
Inactivated SARS-CoV-2 induces acute respiratory distress syndrome in human ACE2-transgenic mice. Signal transduction and targeted therapy 6 (1) (2021)
Xuemei He, Cai He, Weiqi Hong, Kang Zhang, Yanping Qian
The challenges of COVID-19 Delta variant: Prevention and vaccine development. MedComm 2 (4) (2021)
Xuemei He, Weiqi Hong, Jingyun Yang, Hong Lei, Tianqi Lu, Cai He, Zhenfei Bi, Xiangyu Pan, Yu Liu, Lunzhi Dai, Wei Wang, Canhua Huang, Hongxin Deng, Yanping Qian
Spontaneous apoptosis of cells in therapeutic stem cell preparation exert immunomodulatory effects through release of phosphatidylserine. Signal transduction and targeted therapy 6 (1) (2021)
Xuemei He, Weiqi Hong, Xiangyu Pan, Guangwen Lu, Yanping Qian
SARS-CoV-2 Omicron variant: Characteristics and prevention. MedComm 2 (4) (2021)
Dandan Wan, Tingfu Du, Weiqi Hong, Li Chen, Haiying Que, Shuai-Yao Lu, Xiao-Zhong Peng
Neurological complications and infection mechanism of SARS-COV-2. Signal transduction and targeted therapy 6 (1) (2021)
Zhenfei Bi, Weiqi Hong, Jingyun Yang, Shuaiyao Lu, Xiaozhong Peng
Animal models for SARS-CoV-2 infection and pathology. MedComm 2 (4) (2021)
Jingyun Yang, Wei Wang, Zimin Chen, Shuaiyao Lu, Fanli Yang, Zhenfei Bi, Linlin Bao, Fei Mo, Xue Li, Yong Huang, Weiqi Hong, Yun Yang, Yuan Zhao, Fei Ye, Sheng Lin, Wei Deng, Hua Chen, Hong Lei, Ziqi Zhang, Min Luo, Hong Gao, Yue Zheng, Yanqiu Gong, Xiaohua Jiang, Yanfeng Xu, Qi Lv, Dan Li, Manni Wang, Fengdi Li, Shunyi Wang, Guanpeng Wang, Pin Yu, Yajin Qu, Li Yang, Hongxin Deng, Aiping Tong, Jiong Li, Zhenling Wang, Jinliang Yang, Guobo Shen, Zhiwei Zhao, Yuhua Li, Jingwen Luo, Xiao-Zhong Peng, Wenhai Yu, Mengli Yang, Jingwen Xu, Junbin Wang, Haiyan Li, Haixuan Wang, Dexuan Kuang, Panpan Lin, Zhengtao Hu, Wei Guo, Wei Cheng, Yanlin He, Xiangrong Song, Chong Chen, Zhihong Xue, Shaohua Yao, Lu Chen, Xuelei Ma, Siyuan Chen, Maling Gou, Wei Jin Huang, You-Chun Wang, Changfa Fan, Zhixin Tian, Ming Shi, Fu-Sheng Wang, Lunzhi Dai, Xue-Jie Yu, Gen Li, Guangyu Wang, Yong Peng, Zhiyong Qian, Canhua Huang, Johnson Yiu-Nam Lau, Zhenglin Yang, Yuquan Wei, Xiaobo Cen, Xiaozhong Peng, Chuan Qin, Kang Zhang, Guang-Wen Lu, Yanping Qian
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity. Nature 586 (7830) (2020)

Weiqi Hong.css-eqlu8i{font-size:small;padding-left:4px;} (Hong Weiqi)

Publication Activity (10 Years)

Top Topics

Top Venues

Weiqi Hong (Hong Weiqi)